February 26, 2022

Ursodeoxycholic Acid in Treating Parenteral Nutrition

Parenteral nutrition associated cholestasis is a common complication of prolonged and exclusive parenteral nutrition. Ursodeoxycholic acid may be used to reduce the duration. Infants subjected to major surgery are often unable to receive enteral nutrition for a long period of time, during which they require exclusive PN. After that, enteral nutrition is slowly introduced alongside… Continue reading Ursodeoxycholic Acid in Treating Parenteral Nutrition

February 26, 2022

Gut microbial signatures and risk of developing type 2 diabetes

Type 2 diabetes (T2D) is a common disease, characterized by imbalances in the regulation of blood sugar and blood lipid levels, blood platelet aggregation, and blood pressure. The gut microbial signatures are been studied to assess the risk of developing Type 2 diabetes mellitus. Many genetic variants associated with T2D have been identified, partly explaining… Continue reading Gut microbial signatures and risk of developing type 2 diabetes

February 26, 2022

Connection between uric acid levels and heart health

Cardiovascular sicknesses (CVD) and serum uric acid levels relation are the primary motive of demise worldwide. This is probably because of an multiplied occurrence of persistent sicknesses which includes obesity, diabetes, high blood pressure, dyslipidemia, and hyperuricemia. Evidence indicates that multiplied tiers of serum uric acid levels (SUA) are related to the improvement of high… Continue reading Connection between uric acid levels and heart health

February 26, 2022

Fatty Acids and its relation to the mortality

Biomarkers Of Dietary Omega-6 Fatty Acids And Mortality Recommendations for nutritional intake of omega-6 polyunsaturated fatty acids for cardiovascular ailment prevention remain controversial and inconsistent. Most research assessed fatty acids in blood compartments, whereas adipose tissue changed into less commonly used. Among the 30 prospective research, 10 477 overall incident CVD events, 4508 CVD deaths, 11 857 incident CHD events, and 3705 incident ischemic strokes occurred. The results of omega-three fatty acids (FAs), on cardiovascular effects are uncertain. We aimed to decide the effectiveness of omega-three FAs on deadly and non-deadly cardiovascular effects… Continue reading Fatty Acids and its relation to the mortality

1 35 36 37 38 39 40